Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | MTOR | P42345 | 18/20 | 0.37 |
| ▸ | PIK3CA | P42336 | 15/20 | 0.36 |
| ▸ | DRD2 | P14416 | 1/20 | 0.36 |
| ▸ | DRD4 | P21917 | 1/20 | 0.36 |
| ▸ | DRD3 | P35462 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL617257 | 0.78 | ALOX5AP (0.35) | — | |
| SCHEMBL15929576 | 0.77 | MTOR (0.35) | CYP1A2CYP2E1CYP2A6CYP2B6CYP2C19 | |
| SCHEMBL8526099 | 0.75 | CYP1A2 (0.41) | CYP1A2CYP2C19DRD2 | |
| SCHEMBL15307380 | 0.74 | ALK (0.35) | — | |
| SCHEMBL20208683 | 0.74 | CYP1A2 (0.43) | CYP1A2CYP2C19 | |
| SCHEMBL20973025 | 0.72 | — | — | |
| SCHEMBL19584510 | 0.71 | GRM5 (0.39) | — | |
| SCHEMBL14720794 | 0.71 | EGLN1 (0.40) | — | |
| SCHEMBL30423197 | 0.71 | GABRP (0.41) | — | |
| SCHEMBL643187 | 0.71 | GABRP (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120092003-A | CDK protein degrading agents, pharmaceutical compositions and therapeutic uses | 拜欧斯瑞克斯公司 | 2025-06-03 | — | — | CN | disclosed |